SAM
EW icon

Solaris Asset Management’s Edwards Lifesciences EW Stock Holding History

Solaris Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-300
Closed -$4K – 210
2014
Q1 		$4K Hold
300
– – ﹤0.01% 203
2013
Q4 		$3K Hold
300
– – ﹤0.01% 229
2013
Q3 		$3K Sell
300
-30,300
-99% -$354K ﹤0.01% 229
2013
Q2 		$343K Buy
+30,600
New +$362K 0.27% 91

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Solaris Asset Management's EW Position: Q2 2014 in Review

Solaris Asset Management sold out of Edwards Lifesciences (EW) in Q2 2014, closing a stake of 300 shares — an estimated $4K sold.

Solaris Asset Management first reported a position in EW in Q2 2013 and held it in 4 quarters. The position peaked at $343K in Q2 2013. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Solaris Asset Management reported no remaining Edwards Lifesciences position as of Q2 2014 after selling out during the quarter.
  • Solaris Asset Management sold 300 Edwards Lifesciences shares in Q2 2014, an estimated $4K.
  • Solaris Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 4 quarters.
  • Solaris Asset Management's Edwards Lifesciences position peaked at $343K in Q2 2013.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Solaris Asset Management's 13F filing for Q2 2014, filed 18 Jul 2014.